Health Condition 1: E889- Metabolic disorder, unspecified
Conditions
Interventions
None listed
Sponsors
Maharao Shekhaji Regional Ayurveda Research Institute Jaipur Rajasthan
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients between the age group of 18 to 60 years of either sex. 2.Freshly diagnosed cases of Dyslipidemia and Medoroga on the basis of criteria given by NCEP-ATPIII Serum Cholesterol more than or equal 200 mg/dl Serum Triglycerides more than or equal 150mg/dl LDL Cholesterol more than or equal 130mg/dl HDL Cholesterol less than 40mg/dl. 3.Patients willing to give written informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1.Patients with age below 18 years and above 60 years. 2.Patients having medical history of Unstable angina, Myocardial Infarction, Symptomatic patients with clinical evidence of Heart failure, Patients with poorly controlled hypertension more than or equal 160/100 mmHg, Patients with uncontrolled Diabetes mellitus HbA1C more than or equal 8 percent, Impaired Renal function Creatinine more than or equal 2 mg/dl, Patients with concurrent serious Hepatic Dysfunction defined as AST and ALT more than 3 times of the upper normal limit or Renal Dysfunction defined as S. creatinine more than 1.4 mg/dl, Patients suffering from hypothyroidism, Patients with evidence of malignancy, Patients on oral contraceptives, Alcoholics and drug abusers, Hypersensitivity to any of the trial drugs or their ingredients, Patients who have completed participation in any other clinical trial drugs or their ingredients, Patients who have received any cholesterol lowering medication Modern Drug within last two weeks. 3.Pregnancy, Lactation and patients having Dyslipidemia due to drugs e.g. Glucocorticoids, Diuretics.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| a)Assessment of changes in specific symptoms of Dyslipidemia. b) Change in Body weight, Body Mass Index (BMI). c) Clinical assessment of safety profile through LFT and RFT. d)The advent of any biological intolerability/ADR/AE. e) Change in Quality of Life (SF-36) score. f) Change in status of Agni (Jatharagni Assessment) g) Change in Swasthya Assessment Scale. Timepoint: 90 days | — |
Primary
| Measure | Time frame |
|---|---|
| Change in Lipid Profile.Timepoint: 90 days | — |
Countries
India
Contacts
Public ContactVidhya Bharti Sharma
Maharao Shekhaji Regional Ayurveda Research Institute, Jaipur Rajasthan
Outcome results
None listed